- Home
- GRI vs WHLR Comparison
GRI vs WHLR Comparison
Compare GRI & WHLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRI
- WHLR
- Stock Information
- Founded
- GRI 2018
- WHLR 2011
- Country
- GRI United States
- WHLR United States
- Employees
- GRI N/A
- WHLR N/A
- Industry
- GRI Biotechnology: Pharmaceutical Preparations
- WHLR Real Estate Investment Trusts
- Sector
- GRI Health Care
- WHLR Real Estate
- Exchange
- GRI Nasdaq
- WHLR Nasdaq
- Market Cap
- GRI 4.3M
- WHLR 4.2M
- IPO Year
- GRI N/A
- WHLR 2012
- Fundamental
- Price
- GRI $1.64
- WHLR $1.97
- Analyst Decision
- GRI Strong Buy
- WHLR
- Analyst Count
- GRI 2
- WHLR 0
- Target Price
- GRI $22.50
- WHLR N/A
- AVG Volume (30 Days)
- GRI 175.4K
- WHLR 89.3K
- Earning Date
- GRI 11-14-2025
- WHLR 11-07-2025
- Dividend Yield
- GRI N/A
- WHLR N/A
- EPS Growth
- GRI N/A
- WHLR N/A
- EPS
- GRI N/A
- WHLR N/A
- Revenue
- GRI N/A
- WHLR $102,799,000.00
- Revenue This Year
- GRI N/A
- WHLR N/A
- Revenue Next Year
- GRI N/A
- WHLR N/A
- P/E Ratio
- GRI N/A
- WHLR N/A
- Revenue Growth
- GRI N/A
- WHLR N/A
- 52 Week Low
- GRI $1.10
- WHLR $2.12
- 52 Week High
- GRI $17.51
- WHLR $11,578.00
- Technical
- Relative Strength Index (RSI)
- GRI 41.46
- WHLR 26.26
- Support Level
- GRI $1.60
- WHLR $2.79
- Resistance Level
- GRI $1.79
- WHLR $3.06
- Average True Range (ATR)
- GRI 0.17
- WHLR 0.36
- MACD
- GRI -0.04
- WHLR -0.14
- Stochastic Oscillator
- GRI 7.25
- WHLR 7.38
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.